The impact of heterogeneity on the analysis of platform trials with normally distributed outcomes
Abstract Background A platform trial approach allows adding arms to on-going trials to speed up intervention discovery programs.A control arm remains open for recruitment in a platform trial while intervention arms may be added after the onset of the study and could be terminated early for efficacy and/or futility when early stopping is allowed.The